| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$485 |
Dignity Health Arizona joins Sapphire Study
|
2 Feb 2026 8:40AM |
$3.530 |
$3.070 |
fallen by
13.03%
|
|
| Macro Metals Limited (M4M) ORDINARY FULLY PAID |
Materials |
$32 |
Nyapiri Macro Mining executes framework agreement with BHP
|
2 Feb 2026 8:38AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$6 |
NME divests Arika Joint Venture interest
|
2 Feb 2026 8:37AM |
$0.019 |
$0.018 |
fallen by
5.26%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- Nex Metals divests 20% interest in Arika Joint Venture.
- Transaction includes $2.5 million in cash and Arika shares.
- Funds to support Kookynie Tailings Project and exploration in Australia.
- Shareholder approval required for transaction completion.
- NME retains significant shareholding in Arika.
- NME focusing on opportunities in Egypt's Eastern Desert.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$40 |
NME: NME divests Arika Joint Venture interest
|
2 Feb 2026 8:37AM |
$0.032 |
$0.036 |
risen by
12.50%
|
|
ARI - Price-sensitive ASX Announcement
Full Release
Key Points
- NME divests 20% interest in Yundamindra and Kookynie Gold Projects.
- Transaction with Arika Resources Limited valued at $2.5 million cash and shares.
- Shareholder approval required for transaction completion.
- NME retains significant shareholding in Arika.
- Proceeds to fund Kookynie Tailings Project and exploration in Western Australia.
- NME also exploring opportunities in Egypt's Eastern Desert.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sierra Nevada Gold Inc. (SNX) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$27 |
Samples highlight priority drill targets at As Safra
|
2 Feb 2026 8:36AM |
$0.037 |
$0.056 |
risen by
51.35%
|
|
SNX - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade copper and gold mineralization confirmed at As Safra.
- Rock chip sampling revealed up to 9.66% copper and 12.6 g/t gold.
- Three priority Cu–Au target corridors identified for drilling.
- Drilling to commence upon grant of exploration licenses, expected by late March.
- Historical drilling by BRGM supports the presence of a vertically extensive mineral system.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$646 |
Weekly NTA Estimate
|
2 Feb 2026 8:35AM |
$3.140 |
$2.820 |
fallen by
10.19%
|
|
| Magnum Mining and Exploration Limited (MGU) ORDINARY FULLY PAID |
Materials |
$16 |
HIGH-GRADE WET MOUNTAIN REE ACQUISITION COMPLETE
|
2 Feb 2026 8:33AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
MGU - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Wet Mountain REE Project complete.
- Ownership of Wyoming Critical Minerals, Inc. secured.
- Historical assays report up to 7.99% TREE.
- Exploration campaign planned to unlock project's potential.
- Project aligns with US critical minerals focus.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aland Equity Group Limited (AEG) ORDINARY FULLY PAID |
Financials |
$19 |
Application for quotation of securities - AEG
|
2 Feb 2026 8:31AM |
$0.035 |
$0.034 |
fallen by
2.86%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$424 |
Update - Notification of buy-back - RG8
|
2 Feb 2026 8:31AM |
$3.010 |
$2.910 |
fallen by
3.32%
|
|
| Provaris Energy Ltd (PV1) ORDINARY FULLY PAID |
Energy |
$11 |
MOU with Yinson and Himile to Advance LCO2 Tank Production
|
2 Feb 2026 8:30AM |
$0.012 |
$0.012 |
fallen by
0%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$595 |
Clinical & Financial Update
|
2 Feb 2026 8:30AM |
$11.000 |
$11.860 |
risen by
7.82%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$568 |
Update - Notification of buy-back - RG1
|
2 Feb 2026 8:29AM |
$2.460 |
$2.350 |
fallen by
4.47%
|
|
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$639 |
Distributor appointed for Balkan markets
|
2 Feb 2026 8:29AM |
$1.015 |
$0.925 |
fallen by
8.87%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,715 |
Net Tangible Asset Backing
|
2 Feb 2026 8:23AM |
$4.220 |
$4.290 |
risen by
1.66%
|
|
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$192 |
Drilling returns high-grade gold hits from Consol & Spurs
|
2 Feb 2026 8:23AM |
$0.550 |
$0.620 |
risen by
12.73%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Waratah Minerals Limited's drilling projects at Consol and Spurs have returned high-grade gold hits.
- Significant gold intercepts were found at Consols, with some reaching up to 14 g/t Au.
- Drilling at Spurs also showed promising gold grades, with some intercepts over 26 g/t Au.
- The drilling results demonstrate the potential for substantial gold resources in these areas.
- The mineralisation at both sites is generally subvertical, implying that the intercepts likely represent more than 80% of the true thickness.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$190 |
Notification of Results/Reporting Date
|
2 Feb 2026 8:21AM |
$12.240 |
$11.740 |
fallen by
4.08%
|
|
| BlueScope Steel Limited (BSL) ORDINARY FULLY PAID |
Materials |
$12,428 |
Tania Archibald commences as MD&CEO of BlueScope
|
2 Feb 2026 8:21AM |
$30.240 |
$28.370 |
fallen by
6.18%
|
|
BSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Tania Archibald starts as MD&CEO of BlueScope Steel.
- Mark Vassella steps down after eight years.
- $2 billion investment program entering its final phase.
- Focus on shareholder value and cash flow enhancement.
- Board rejects undervalued acquisition proposal.
- Safety, customer value, and operational excellence as strategic priorities.
- Four initiatives: execution of initiatives, operational simplification, surplus land value realization, and balance sheet evolution.
- Upcoming update at 1H FY2026 Financial Results on 16 February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$73,825 |
Notice of HY26 results release and briefing
|
2 Feb 2026 8:21AM |
$181.420 |
$152.170 |
fallen by
16.12%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$6,659 |
APRR and AREA Toll Increases
|
2 Feb 2026 8:21AM |
$4.970 |
$4.590 |
fallen by
7.65%
|
|
| Adheris Health Limited (AHE) ORDINARY FULLY PAID |
Health Care |
$13 |
Non-Deal Roadshow Presentation & Operating Cost Update
|
2 Feb 2026 8:20AM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
AHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-deal roadshow presentation by Adheris Health Limited.
- Introduction of a cost-out program targeting a 30% reduction in operating expenses by FY27.
- Launch of a new technology platform to enhance scalability.
- Shift in commercial focus to high-growth categories such as immunology and diabetes.
- Reduced dependency on vaccine revenue.
- Enhancements in digital engagement tools for personalized patient experiences.
- Strengthening of relationships with pharmaceutical and pharmacy partners.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$93 |
Biome secures distribution with Fullscript Canada
|
2 Feb 2026 8:20AM |
$0.450 |
$0.420 |
fallen by
6.67%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Biome Australia Limited secured distribution for its Canadian range through Fullscript, a major practitioner distribution platform in North America.
- All Biome Activated Probiotics products are approved for launch on Fullscript Canada, with the launch planned for February 2026.
- Fullscript serves over 100,000 healthcare practitioners and 5 million patients across North America.
- The partnership with Fullscript complements Biome's existing relationship with Ecotrend Ecologics to cover the Canadian market comprehensively.
- Fullscript partnership is a significant milestone in Biome's Canadian expansion strategy, facilitating access to practitione- to-patient supplement dispensing.
- Biome Australia's Activated Probiotics are supported by clinical research and aim to improve health outcomes via practitioner channels.
- The company is building scale across key markets including Canada, Ireland, New Zealand, and the UK as part of its Vision 27 international expansion strategy.
- Biome Australia's partnership strategy in Canada ensures dual-channel coverage through both traditional wholesale and digital direct-to-patient dispensing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$1,216 |
Response to Media Articles
|
2 Feb 2026 8:20AM |
$8.680 |
$6.300 |
fallen by
27.42%
|
|
EOS - Price-sensitive ASX Announcement
Full Release
Key Points
- EOS is aware of media speculation about shifting its headquarters and listing to Europe.
- No unannounced decisions have been made by the EOS Board regarding relocation.
- EOS expects significant growth in demand for defense technology, especially in Europe.
- The company secured a 100kW High Energy Laser Weapons order worth A$125 million from a European customer.
- EOS plans to list shares on the Frankfurt Open Market.
- An agreement was made to acquire the assets and business of MARSS group in Europe.
- EOS continues to explore opportunities for market expansion globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,113 |
Update - Notification of buy-back - KAR
|
2 Feb 2026 8:20AM |
$1.695 |
$1.550 |
fallen by
8.55%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$22 |
Strong Zr vs Hf Correlation at Blue Lagoon
|
2 Feb 2026 8:20AM |
$0.063 |
$0.068 |
risen by
7.94%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,819 |
Update - Notification of buy-back - DNL
|
2 Feb 2026 8:19AM |
$3.510 |
$3.270 |
fallen by
6.84%
|
|